In an experimental stroke model, the administration of BDNF through the nasal route was found to increase anti-inflammatory cytokine IL-10 levels but to decrease pro-inflammatory cytokine tumour necrosis factor-alpha levels [71]. Here, IL10 is linked to stroke disorder.